According to Amryt Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.86982. At the end of 2022 the company had a P/S ratio of 1.82.
Year | P/S ratio | Change |
---|---|---|
2022 | 1.82 | -41.27% |
2021 | 3.10 | 11.94% |
2020 | 2.77 |